Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy

Movement Disorders

Volumn 29, Issue 3, 2014, Pages 388-395

  Flabeau, Olivier ^a   Meissner, Wassilios G ^a,b,c   Ozier, Annaig ^a,d,e   Berger, Patrick ^a,d,e   Tison, François ^a,b,c   Fernagut, Pierre Olivier ^b,c  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b INSTITUT DES MALADIES NEURODÉGÉNÉRATIVES   (France)

^c CNRS   (France)

^d CENTRE DE RECHERCHE CARDIO THORACIQUE DE BORDEAUX   (France)

^e INSERM   (France)

Author keywords

Breathing disorder; Multiple system atrophy; Raphe; Transgenic model; synuclein

Indexed keywords

ALPHA SYNUCLEIN; PROTEOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY PLETHYSMOGRAPHY; BRAIN STEM; BREATHING PATTERN; BREATHING VARIABILITY; CELL COUNT; CELL INCLUSION; CONTROLLED STUDY; DEPLETION; EXPIRATORY FLOW; EXPIRATORY RESERVE VOLUME; EXPIRATORY TIME; GENETIC MODEL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INSPIRATORY TIME; MALE; MOUSE; NONHUMAN; NUCLEUS RAPHE OBSCURUS; NUCLEUS RAPHE PALLIDUS; PEAK EXPIRATORY FLOW; PEAK INSPIRATORY FLOW; PLETHYSMOGRAPH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAPHE NUCLEUS; RESPIRATORY FUNCTION; SEROTONINERGIC NERVE CELL; SHY DRAGER SYNDROME; TIDAL VOLUME; ANIMAL; BIOLOGICAL MODEL; BREATHING; C57BL MOUSE; DISEASE MODEL; GENETICS; HUMAN; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BRAIN STEM; DISEASE MODELS, ANIMAL; HUMANS; INCLUSION BODIES; MALE; MICE, INBRED C57BL; MODELS, GENETIC; MULTIPLE SYSTEM ATROPHY; NEURONS; RESPIRATION;

EID: 84896122792     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25804     Document Type: Article

References (57)

1. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-676.
2. Silber MH, Levine S. Stridor and death in multiple system atrophy. Mov Disord 2000;15:699-704.
3. Vetrugno R, Provini F, Cortelli P, et al. Sleep disorders in multiple system atrophy: a correlative video-polysomnographic study. Sleep Med 2004;5:21-30.
4. Iranzo A. Management of sleep-disordered breathing in multiple system atrophy. Sleep Med 2005;6:297-300.
5. Sadaoka T, Kakitsuba N, Fujiwara Y, Kanai R, Takahashi H. Sleep-related breathing disorders in patients with multiple system atrophy and vocal fold palsy. Sleep 1996;19:479-484.
6. Ghorayeb I, Bioulac B, Tison F. Sleep disorders in multiple system atrophy. J Neural Transm 2005;112:1669-1675.
7. Shimohata T, Shinoda H, Nakayama H, et al. Daytime hypoxemia, sleep-disordered breathing, and laryngopharyngeal findings in multiple system atrophy. Arch Neurol 2007;64:856-861.
8. Manni R, Morini R, Martignoni E, Pacchetti C, Micieli G, Tartara A. Nocturnal sleep in multisystem atrophy with autonomic failure: polygraphic findings in ten patients. J Neurol 1993;240:249-250.
9. Chokroverty S, Sharp JT, Barron KD. Periodic respiration in erect posture in Shy-Drager syndrome. J Neurol Neurosurg Psychiatry 1978;41:980-986.
10. Tsuda T, Onodera H, Okabe S, Kikuchi Y, Itoyama Y. Impaired chemosensitivity to hypoxia is a marker of multiple system atrophy. Ann Neurol 2002;52:367-371.
11. McNicholas WT, Rutherford R, Grossman R, Moldofsky H, Zamel N, Phillipson EA. Abnormal respiratory pattern generation during sleep in patients with autonomic dysfunction. Am Rev Respir Dis 1983;128:429-433.
12. Castaigne P, Laplane D, Autret A, Bousser MG, Gray F, Baron JC. Syndrome de Shy et Drager avec troubles du rythme respiratoire et de la vigilance. A propos d'un cas anatomo-clinique. Rev Neurol (Paris) 1977;133(8-9):455-466.
13. Kavey NB, Whyte J, Blitzer A, Gidro-Frank S. Sleep-related laryngeal obstruction presenting as snoring or sleep apnea. Laryngoscope 1989;99(8 pt 1):851-854.
14. Munschauer FE, Loh L, Bannister R, Newsom-Davis J. Abnormal respiration and sudden death during sleep in multiple system atrophy with autonomic failure. Neurology 1990;40:677-679.
15. Kokturk N, Gursel G, Kuruoglu R, Kervan F, Baysal AI. Multiple system atrophy presenting with acute respiratory failure due to diaphragmatic dysfunction. Tuberk Toraks 2006;54:370-373.
16. Cormican LJ, Higgins S, Davidson AC, Howard R, Williams AJ. Multiple system atrophy presenting as central sleep apnoea. Eur Respir J 2004;24:323-325.
17. Glass GA, Josephs KA, Ahlskog JE. Respiratory insufficiency as the primary presenting symptom of multiple-system atrophy. Arch Neurol 2006;63:978-981.
18. Meissner WG, Vital A, Ghorayeb I, Guehl D, Tison F. Dyspnea as first sign of autonomic failure in postmortem confirmed multiple system atrophy. Mov Disord 2010;25:1997-1998.
19. Williams A, Hanson D, Calne DB. Vocal cord paralysis in the Shy-Drager syndrome. J Neurol Neurosurg Psychiatry 1979;42:151-153.
20. Yamaguchi M, Arai K, Asahina M, Hattori T. Laryngeal stridor in multiple system atrophy. Eur Neurol 2003;49:154-159.
21. Tada M, Kakita A, Toyoshima Y, et al. Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death. Brain 2009;132(pt 7):1810-1819.
22. Shimohata T, Ozawa T, Nakayama H, Tomita M, Shinoda H, Nishizawa M. Frequency of nocturnal sudden death in patients with multiple system atrophy. J Neurol 2008;255:1483-1485.
23. Flabeau O, Meissner WG, Tison F. Multiple system atrophy: current and future approaches to management. Ther Adv Neurol Disord 2010;3:249-263.
24. Benarroch EE, Schmeichel AM, Low PA, Parisi JE. Depletion of ventromedullary NK-1 receptor-immunoreactive neurons in multiple system atrophy. Brain 2003;126(pt 10):2183-2190.
25. Benarroch EE, Schmeichel AM, Low PA, Parisi JE. Involvement of medullary serotonergic groups in multiple system atrophy. Ann Neurol 2004;55:418-422.
26. Benarroch EE, Schmeichel AM, Low PA, Parisi JE. Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy. Brain 2007;130(pt 2):469-475.
27. Benarroch EE. Brainstem respiratory control: substrates of respiratory failure of multiple system atrophy. Mov Disord 2007;22:155-161.
28. Schwarzacher SW, Rub U, Deller T. Neuroanatomical characteristics of the human pre-Botzinger complex and its involvement in neurodegenerative brainstem diseases. Brain 2011;134(pt 1):24-35.
29. Benarroch EE. Brainstem respiratory chemosensitivity: new insights and clinical implications. Neurology 2007;68:2140-2143.
30. Kahle PJ, Neumann M, Ozmen L, et al. Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep 2002;3:583-588.
31. Shults CW, Rockenstein E, Crews L, et al. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J Neurosci 2005;25:10689-10699.
32. Yazawa I, Giasson BI, Sasaki R, et al. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 2005;45:847-859.
33. Fernagut PO, Ghorayeb I, Diguet E, Tison F. In vivo models of multiple system atrophy. Mov Disord 2005;20(suppl 12):S57-S63.
34. Fernagut PO, Tison F. Animal models of multiple system atrophy. Neuroscience 2012;211:77-82.
35. Kahle PJ. alpha-Synucleinopathy models and human neuropathology: similarities and differences. Acta Neuropathol 2008;115:87-95.
36. Viemari JC, Roux JC, Tryba AK, et al. Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J Neurosci 2005;25:11521-11530.
37. Bartlett D Jr, Tenney SM. Control of breathing in experimental anemia. Respir Physiol 1970;10:384-395.
38. Telgkamp P, Cao YQ, Basbaum AI, Ramirez JM. Long-term deprivation of substance P in PPT-A mutant mice alters the anoxic response of the isolated respiratory network. J Neurophysiol 2002;88:206-213.
39. Gray PA, Janczewski WA, Mellen N, McCrimmon DR, Feldman JL. Normal breathing requires pre-Botzinger complex neurokinin-1 receptor-expressing neurons. Nat Neurosci 2001;4:927-930.
40. Wang H, Germanson TP, Guyenet PG. Depressor and tachypneic responses to chemical stimulation of the ventral respiratory group are reduced by ablation of neurokinin-1 receptor-expressing neurons. J Neurosci 2002;22:3755-3764.
41. West MJ, Slomianka L, Gundersen HJ. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991;231:482-497.
42. Iranzo A, Santamaria J, Tolosa E. Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group. Lancet 2000;356:1329-1330.
43. Lipp A, Schmelzer JD, Low PA, Johnson BD, Benarroch EE. Ventilatory and cardiovascular responses to hypercapnia and hypoxia in multiple-system atrophy. Arch Neurol 2010;67:211-216.
44. Yumino D, Bradley TD. Central sleep apnea and Cheyne-Stokes respiration. Proc Am Thorac Soc 2008;5:226-236.
45. Corcoran AE, Hodges MR, Wu Y, Wang W, Wylie CJ, Deneris ES, Richerson GB. Medullary serotonin neurons and central CO2 chemoreception. Respir Physiol Neurobiol 2009;168(1-2):49-58.
46. Hodges MR, Richerson GB. The role of medullary serotonin (5-HT) neurons in respiratory control: contributions to eupneic ventilation, CO2 chemoreception, and thermoregulation. J Appl Physiol 2010;108:1425-1432.
47. Depuy SD, Kanbar R, Coates MB, Stornetta RL, Guyenet PG. Control of breathing by raphe obscurus serotonergic neurons in mice. J Neurosci 2011;31:1981-1990.
48. da Silva GS, Giusti H, Benedetti M, Dias MB, Gargaglioni LH, Branco, LG, Glass ML. Serotonergic neurons in the nucleus raphe obscurus contribute to interaction between central and peripheral ventilatory responses to hypercapnia. Pflugers Arch 2011;462:407-418.
49. Menuet C, Borghgraef P, Matarazzo V, et al. Raphe tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease. Respir Physiol Neurobiol 2011;178:290-303.
50. Mellen NM, Thoby-Brisson M. Respiratory circuits: development, function and models. Curr Opin Neurobiol 2012;22:676-685.
51. Benarroch EE, Schmeichel AM, Parisi JE. Preservation of branchimotor neurons of the nucleus ambiguus in multiple system atrophy. Neurology 2003;60:115-117.
52. Stemberger S, Poewe W, Wenning GK, Stefanova N. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure. Exp Neurol 2010;224:459-464.
53. Cao Y, Fujito Y, Matsuyama K, Aoki M. Effects of electrical stimulation of the medullary raphe nuclei on respiratory movement in rats. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 2006;192:497-505.
54. Kobayashi S, Fujito Y, Matsuyama K, Aoki M. Raphe modulation of the pre-Botzinger complex respiratory bursts in in vitro medullary half-slice preparations of neonatal mice. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 2010;196:519-528.
55. Richter DW, Manzke T, Wilken B, Ponimaskin E. Serotonin receptors: guardians of stable breathing. Trends Mol Med 2003;9:542-548.
56. Ptak K, Yamanishi T, Aungst J, Milescu LS, Zhang R, Richerson GB, Smith JC. Raphe neurons stimulate respiratory circuit activity by multiple mechanisms via endogenously released serotonin and substance P. J Neurosci 2009;29:3720-3737.
57. Kuzdas D, Stemberger S, Gaburro S, Stefanova N, Singewald N, Wenning GK. Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence. Exp Neurol 2013;247:531-5363.